2:56 PM
 | 
Jan 09, 2019
 |  BC Extra  |  Company News

Elevian, AI company Insilico partner to find anti-aging candidates in GDF11 pathway

Elevian Inc. (Allston, Mass.) partnered with AI company Insilico Medicine Inc. (Baltimore, Md.) to use deep-learning technology to discover small molecules that target the GDF11 pathway to treat age-related diseases.

Insilico will apply its generative adversarial networks and reinforcement learning technologies to biological and structural target data from Elevian...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >